Atlas Trials

Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant

Clinical trial NCT05849207 · RECRUITING

Trial details

NCT number
NCT05849207
Sponsor
Ronald Paquette
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Hematologic Malignancies
Start date
2023-10-24
Primary completion
2027-07-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.